Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Donor antigen-primed regulatory T cells permit liver regeneration and phenotype correction in hemophilia A mouse by allogeneic bone marrow stem cells.

Stem cell research & therapy - 8 Jul 2015

Kochat Veena, Kanjirakkuzhiyil Sumod, Baligar Prakash, Nagarajan Perumal, Mukhopadhyay Asok

Abstract excerpt

INTRODUCTION: Cell replacement therapy may be considered as an alternate approach to provide therapeutic dose of plasma factor VIII (FVIII) in patients with hemophilia A (HA). However, immune rejection limits the use of allogeneic cells in this mode of therapy. Here, we have examined the role of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bone Marrow Transplantation
Share to Chemical and Drug Induced Liver Injury

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Factor VIII

Share to Hemophilia A

Share to Immune Tolerance

Share to Kupffer Cells

Share to Liver Regeneration

Share to Transplantation, Homologous

Source

Open in PubMed Open full text

Identifiers

PMID: 26152192
DOI: 10.1186/s13287-015-0119-9
PMCID: PMC4513683

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-26152192-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Donor antigen-primed regulatory T cells permit liver regeneration and phenotype correction in hemophilia A mouse by allogeneic bone marrow stem cells.PMID 26152192Read ↗

Ex vivo expanded autologous polyclonal regulatory T cells suppress inhibitor formation in hemophiliaSemantic proximity Read ↗

Efficient treatment of murine acute GvHD by in vitro expanded donor regulatory T cells.Semantic proximity Read ↗

HLA-A*02:01-directed chimeric antigen receptor/forkhead box P3-engineered CD4+ T cells adopt a regulatory phenotype and suppress established graft-versus-host disease.Semantic proximity Read ↗

Specific removal of alloreactive T-cells to prevent GvHD in hemopoietic stem cell transplantation: rationale, strategies and perspectivesSemantic proximity Read ↗

T regulatory Cell-mediated Immunotherapy for Solid Organ Transplantation: A Clinical PerspectiveSemantic proximity Read ↗

Clinical tolerance in allogeneic hematopoietic stem cell transplantationSemantic proximity Read ↗

Therapeutic application of T regulatory cells in composite tissue allotransplantation.Semantic proximity Read ↗

A Model for Personalized in Vivo Analysis of Human Immune ResponsivenessSemantic proximity Read ↗

Induction of local immunosuppression in allogeneic cell transplantation by cell-type-specific expression of PD-L1 and CTLA4IgSemantic proximity Read ↗

Autologous stem cell transplantation aids autoimmune patients by functional renewal and TCR diversification of regulatory T cellsSemantic proximity Read ↗

Immune tolerance induced by platelet-targeted factor VIII gene therapy in hemophilia A mice is CD4 T cell mediated.Semantic proximity Read ↗

The therapeutic effect of bone marrow-derived liver cells in the phenotypic correction of murine hemophilia A.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.